Krystal Biotech Inc
NASDAQ:KRYS
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
108.01
213.66
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Wall Street
Price Targets
KRYS Price Targets Summary
Krystal Biotech Inc
According to Wall Street analysts, the average 1-year price target for KRYS is 211.93 USD with a low forecast of 196.95 USD and a high forecast of 232.05 USD.
KRYS Last Price Targets
Krystal Biotech Inc
The latest public price target was made on Sep 11, 2024 by Dae Gon Ha from Stifel Nicolaus , who expects KRYS stock to rise by 33% over the next 12 months. You can read more about this price target by viewing the article on TheFly.
Analyst | Price Target | Date | Article |
---|---|---|---|
Dae Gon Ha
Stifel Nicolaus
|
220
USD
Upside 33% |
3 months ago
Sep 11, 2024
|
Krystal Biotech price target raised to $220 from $204 at Stifel
TheFly
|
Alec Stranahan
Bank of America Securities
|
205
USD
Upside 24% |
3 months ago
Sep 2, 2024
|
Krystal Biotech price target raised to $205 from $195 at BofA
TheFly
|
Gavin Clark-Gartner
Evercore ISI
|
206
USD
Upside 25% |
4 months ago
Aug 12, 2024
|
Krystal Biotech price target raised to $206 from $201 at Evercore ISI
TheFly
|
Dae Gon Ha
Stifel Nicolaus
|
204
USD
Upside 24% |
8 months ago
Apr 15, 2024
|
Krystal Biotech (KRYS) PT Raised to $204 at Stifel
StreetInsider
|
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is KRYS's stock price target?
Price Target
211.93
USD
According to Wall Street analysts, the average 1-year price target for KRYS is 211.93 USD with a low forecast of 196.95 USD and a high forecast of 232.05 USD.
What is Krystal Biotech Inc's Revenue forecast?
Projected CAGR
105%
The compound annual growth rate of Krystal Biotech Inc's revenue for the next 4 years is 105%.
What is Krystal Biotech Inc's Net Income forecast?
Projected CAGR
118%
The compound annual growth rate of Krystal Biotech Inc's net income for the next 4 years is 118%.